CDTX

Cidara Therapeutics (CDTX)

Cidara Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CDTX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/14	07:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/09/14	07:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/09/13	05:18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/08/14	05:35	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/08/14	05:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/08/01	06:25	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/07/30	05:45	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/07/30	05:31	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/07/20	05:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/07/20	05:54	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/07/20	05:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/07/20	05:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/07/20	05:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/07/20	05:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/07/19	05:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/06/04	05:38	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/06/04	05:36	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/05/24	05:59	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/05/21	05:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/03/05	06:22	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/02/24	06:05	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:CDTX	Cidara Therapeutics Inc
2024/02/09	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDTX	Cidara Therapeutics Inc
2023/12/22	21:33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDTX	Cidara Therapeutics Inc
2023/11/18	03:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDTX	Cidara Therapeutics Inc
2023/11/17	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDTX	Cidara Therapeutics Inc
2023/11/03	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDTX	Cidara Therapeutics Inc
2023/11/03	05:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CDTX	Cidara Therapeutics Inc
2023/10/13	23:36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDTX	Cidara Therapeutics Inc
2023/09/22	02:24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDTX	Cidara Therapeutics Inc
2023/09/14	05:24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDTX	Cidara Therapeutics Inc